At a glance
Dialog Solutions offers premium content, services and software products to help you manage critical business needs.
The company brings together Pi2’s drug safety software and tools, ProQuest Corporate’s powerful Dialog content platform and its products and services under a single umbrella organisation. Designed to offer clarity and visibility in our markets, this change also brings us closer to our customers and their needs.
As a leading global data provider, with decades of experience in a range of sectors, our credentials in the life sciences industry, in particular, are second to none. We are proud to count several top 10 global pharmaceutical organisations among our customers. Our key services feature workflows for literature monitoring, innovation and prior art, competitive intelligence and evidence-based medicine.
Our flagship Dialog product is a powerful content platform offering a simple research interface to precision searches across 1.3 billion specialist records. Our specialist topics include biomedical, engineering, patents, news and business, dissertations and thesis content, not freely available online. These enable researchers and information professionals to achieve precise answers that inform critical decisions and solve regulatory challenges.
Dialog Solutions is owned and operated by ProQuest LLC and its office locations include Ann Arbor, Michigan, USA, London, Amsterdam, Milan as well as offices in China and Japan.
- Our company is part of the CIG group based in New York
- Dialog Solutions is part of the wider ProQuest family and you can find out all about them here
- ExLibris is a key part of the group and you can find out all about their company, products and services here
- Dialog Solutions’ acquired Pi2 and integrated the Drug Safety Triager, Literature Review Services and PinPoint products into its offer.